BridgeMD
New treatment option for Heart Failure
Official title Project 4: ACHIEVE PATHFINDER
ClinicalTrials.gov ID: NCT06070428
What this study is testing
- What it's testing
- ACHIEVE-P4: PATHFINDER is a randomized, blinded clinical trial of portable air cleaners (PAC) provided at the time of hospital discharge to Heart Failure (HF) patients. It will be carried out at Henry Ford Hospitals.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Currently in the emergency room or hospitalized with plan to be discharged to home, or
- Diagnosis of heart failure
- BNP\>200 ng/L or NTproBNP\>1000 ng/L during hospitalization or within 1 month prior to screening
- Expected ability to fully participate in study (can tolerate study processes, no long travel)
You likely can't join if
- Hemodialysis dependent
- If dialysis is being considered by participant's care team and their eGFR value is \<30 mL/min/1.73 sq m
- Life expectancy of less than one year
- Inability to provide written informed consent
- Age less than 18 years old
- Patients with a left ventricular assist device (LVAD)
See the full eligibility criteria
- Currently in the emergency room or hospitalized with plan to be discharged to home, or
- Diagnosis of heart failure
- BNP\>200 ng/L or NTproBNP\>1000 ng/L during hospitalization or within 1 month prior to screening
- Expected ability to fully participate in study (can tolerate study processes, no long travel)
- Hemodialysis dependent
- If dialysis is being considered by participant's care team and their eGFR value is \<30 mL/min/1.73 sq m
- Life expectancy of less than one year
- Inability to provide written informed consent
- Age less than 18 years old
- Patients with a left ventricular assist device (LVAD)
- Heart transplant recipients
- Individuals who regularly use a HEPA air cleaner in their home at screening
- Current smokers of nicotine or marijuana
- Severe aortic or mitral valve disease
- Has a scheduled, non-diagnostic cardiac procedure within 30 days prior, or in the next 90 days from screening (e.g. PCI, resynchronization, any cardiac surgery)
- If the PI decides for any reason that participation in the trial is not in the best interest of the patient
The study team makes the final eligibility decision.
Where it's taking place
- Detroit, Michigan, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.